Ticker Short Interest

ARQT Short Interest Intelligence

Arcutis Biotherapeutics Inc positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 30 Jun 2026 Neutral

Neutral

Covering Rally

ARQT is classified as Neutral. Latest reported short interest is 14.0M shares; short interest changed -11.4%, price moved +10.7% since the previous report, short interest is in the 14th percentile, and days to cover is in the 14th percentile. Trend context is constructive.

Setup Score36/100Neutral
Reported Short Interest14.0M-11.4% vs prior report
Days To Cover6.3314.29 percentile
Price Reaction+10.7%since previous short report
Squeeze Pressure36crowding, trend, and pressure
Bearish Conviction6shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-06-30

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-06-26

Squeeze Radar

36

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

6

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

14

Latest short interest is 14.0M shares and days to cover is 6.33.

Divergence

0

Short interest fell while price rose. The bearish trade appears to be unwinding into strength.

Report History

ARQT Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
30 Jun 2026 14019289 15820721 -11.4% 6.33 2213503
15 Jun 2026 15820721 16226183 -2.5% 10.04 1575149
29 May 2026 16226183 17547517 -7.5% 8.44 1922091
15 May 2026 17547517 16879909 4.0% 7.30 2403752
30 Apr 2026 16879909 16583496 1.8% 16.62 1015465
15 Apr 2026 16583496 16801149 -1.3% 15.62 1061977
31 Mar 2026 16801149 15753892 6.7% 11.11 1511820

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.